Back to search

University of British Columbia

Investigating oligodendrocyte dysfunction in Huntington's Disease using oligocortical organoids

Abstract

dc:description

Background: Huntington disease (HD) is an inherited progressive neurodegenerative disorder disease caused by a CAG repeat expansion mutation in the HTT gene. CAG repeat number correlates with age of onset with higher repeats causing earlier onset of symptoms. The impact of mutant HTT (mHTT) on neurons, astrocytes, and microglial cells has been studied in detail, in contrast to its impact on oligodendrocytes, the myelinating cells of the central nervous system. Imaging studies in HD patients and mouse models have shown that white matter pathology precedes symptoms and neuronal degeneration. Furthermore, animal model studies have shown that when mHTT is removed from oligodendrocyte progenitors, myelination improves suggesting mHTT has a direct detrimental effect on oligodendroglia. I hypothesize that mHTT alters oligodendrocyte development, maturation and myelination in a CAG repeat specific manner. Methods: I created a cerebral forebrain model patterned for oligodendrocyte growth and characterized this model. I then investigated the transcriptomic profile of oligocortical organoids expressing mHTT with adult onset (45 CAG repeats, or mHTT-45Q) or juvenile onset (81 CAG repeats, mHTT-81Q). I compared the transcriptional profiles to identify differences between them and then focused on changes in oligodendrocyte-specific genes of direct relevance to the oligodendroglia and myelination deficits being studied. Results: Although oligodendrocyte genes were expressed in the oligocortical organoids at 14 weeks post-differentiation, the levels of these genes were comparable to the general cerebral forebrain model. A greater number of differentially expressed genes were observed in mHTT-81Q organoids compared with mHTT-45Q. Oligodendrocyte specific transcriptional changes showed organoids with mHTT-81Q were mostly affected during earlier periods of development and maturation in oligodendrocytes whereas organoids containing mHTT-45Q had more of an affect on the later stages of maturation oligodendrocytes. This suggests individuals with a higher CAG tract size will have earlier detrimental effects on oligodendrocyte development than individuals who have adult onset. Conclusion: mHTT is seen to have an effect on oligodendrocyte development, maturation and myelination in a CAG repeat specific manner, suggesting that the white matter and myelination pathology in HD is likely to reflect both developmental and degenerative changes.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Medical Genetics
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Witt, Skyla Ivory
Contributors dc:contributor
  • Pouladi, Mahmoud A.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/88520

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Witt, Skyla Ivory. Investigating oligodendrocyte dysfunction in Huntington's Disease using oligocortical organoids. master's thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/88520